Ultrasound-guided Intermediate Cervical Plexus Block
1 other identifier
interventional
29
1 country
1
Brief Summary
The investigators test with the present study design, whether an ultrasound-guided blockade of the cervical plexus in combination with an additional application of local anesthetic to the superficial cervical ansa (facial nerve: cervical branch) leads to an improved quality of anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 31, 2016
CompletedFirst Posted
Study publicly available on registry
June 9, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedResults Posted
Study results publicly available
August 16, 2018
CompletedDecember 19, 2018
November 1, 2018
1.3 years
May 31, 2016
November 20, 2017
November 28, 2018
Conditions
Outcome Measures
Primary Outcomes (2)
Local Anesthetic Supplementation (Frequency)
number of participants who need supplementation of prilocaine 1% by the surgeon (%)
intraoperatively
Local Anesthetic Supplementation (Volume)
volume of prilocaine 1% supplemented by the surgeon (ml)
intraoperatively
Secondary Outcomes (3)
Hoarseness
intraoperatively
Cough
intraoperatively
Dysphagia
intraoperatively
Study Arms (2)
with perivascular block
EXPERIMENTAL1\. ultrasound-guided intermediate cervical plexus block (20ml ropivacaine 0.75%) 2. facial nerve block (cervical branch) (5ml prilocaine 1%) 3. perivascular block (5ml prilocaine 1%)
without perivascular block
EXPERIMENTAL1\. ultrasound-guided intermediate cervical plexus block (20ml ropivacaine 0.75%) 2. facial nerve block (cervical branch) (5ml prilocaine 1%)
Interventions
ultrasound-guided application of 20ml ropivacaine 0.75%
ultrasound-guided application of 5ml prilocaine 1%
ultrasound-guided application of 5ml prilocaine 1%
Eligibility Criteria
You may qualify if:
- internal carotid stenosis: open surgical revascularization
- age over 18 years
- written informed consent
You may not qualify if:
- allergy (local anesthetics)
- pregnancy
- participation in other studies
- drug addiction
- non-cooperative patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Helios Medical Center Schwerin, Department of Anaesthesiology and Intensive Care
Schwerin, Mecklenburg-Vorpommern, 19055, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Ronald Seidel
- Organization
- HELIOS Medical Center Schwerin, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Ronald Seidel, MD
Helios Medical Center Schwerin, Department of Anesthesiology and Intensive care,
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
May 31, 2016
First Posted
June 9, 2016
Study Start
May 1, 2016
Primary Completion
August 1, 2017
Study Completion
August 1, 2017
Last Updated
December 19, 2018
Results First Posted
August 16, 2018
Record last verified: 2018-11
Data Sharing
- IPD Sharing
- Will not share